Shenghe Biotech-B (02898.HK) announced on August 20th that the company will hold a board of directors meeting on August 30, 2024 to approve the mid-term performance of the company and its subsidiaries for the six months ending on June 30, 2024 and its publication.
盛禾生物-B(02898.HK)将于8月30日举行董事会会议以审批中期业绩
Shenghe Biotech-B (02898.HK) will hold a board of directors meeting on August 30th to approve the interim performance.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated